Neurocrine Biosciences, Inc. (NBIX)

139.56 -2.27 (-1.60%) USD  |  NASDAQ  |  Jan 02, 11:18
More

Neurocrine Biosciences Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Pfizer Inc. Upgrade
Masimo Corp. Upgrade
Insulet Corp. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. Upgrade